1. (valid email required)
 

cforms contact form by delicious:days

Archive for November, 2008

One to One Interactive Receives 2 MITX Awards for Comcast

Boston, MA

MITX, the Massachusetts Innovation and Technology Exchange, has announced the winners for the 13 th Annual Interactive Awards and One to One Interactive has received two awards. The two awards garnered by OTOi, a One to One Interactive Company, were acknowledgements for initiatives conducted on behalf of client Comcast.

“We are truly honoured to receive two MITX Awards,” said Jeremi Karnell, Co-Founder and President of One to One Interactive. “We see this recognition as a testament to the incredible work we have been doing for Comcast over the past year; additionally, we are grateful to have received the highest number of nominations, ten overall, for the 2008 MITX Awards. It is encouraging to see that a lot of the work we are doing for our Fortune 1000 clients continues to get recognition for its best-in-class quality and execution.”

The Comcast Business Class Spring Promotion Campaign won the 2008 Best Direct Response Campaign category, receiving unique distinction for the innovative use of sponsorships employed in raising awareness for the Comcast Business Class brand. In doing so, OTOi was able to develop a high level of efficiency in customer acquisition, exceeding Comcast’s ROI expectations by over 700%.

On the sponsorship front, OTOi’s Comcast Pandora Sponsorship won the 2008 Best Use of Sponsorship category. This particular campaign received acknowledgement for the unique sponsorship of a “Comcastic Labs” radio station on the online radio/music discovery site, Pandora.com. The goal of the sponsorship was to raise awareness of Comcast’s High Speed Internet offering in a context that required a high-speed internet connection; in this sponsorship, Comcast’s initial expectations were greatly exceeded by OTOi, more than doubling the normal user interaction rates for typical Pandora online radio stations.

About One to One Interactive
Complete One-To-One Solutions for Brands, Agencies, and Publishers

Established in 1997, One to One Interactive is the first enterprise to assemble a complete solution for brands, agencies, and publishers executing one-to-one marketing strategies. By bringing together one of the nation’s leading digital marketing agencies, the worlds most comprehensive portfolio of permission marketing platforms, unique performance based social media networks, and cutting edge neuromarketing research techniques, the companies of One to One Interactive build informed and creative customer/constituent strategies on the belief that digital media’s ability to enable engaging one-to-one dialogues is the future of marketing.

Please visit one of One to One Interactive’s web sites for more information:

One to One Interactive Receives 2 MITX Awards for Comcast
MITX, the Massachusetts Innovation and Technology Exchange, has announced the winners for the 13 th Annual Interactive Awards and One to One Interactive has received two awards. The two awards garnered by OTOi, a One to One Interactive Company, were acknowledgements for initiatives conducted on behalf of client Comcast. »

Cleveland Clinic Recognizes Multispectral Imaging as Top 10 Medical Innovation for 2009

Nuance system featured in Top Ten video at Cleveland Clinic’s 6th Annual Medical Innovations Summit.

Cleveland, Ohio – November 13, 2008

Cambridge Research & Instrumentation, Inc. (CRi) announced today that the technology of multispectral imaging was ranked as a Top Ten Medical Innovation at Cleveland Clinic’s 6th Annual Medical Innovations Summit.

Click here to go to the Cleveland Clinic Innovations Summit Top 10 webpage.

During the recognition presentation, Dr. Jennifer Hunt, head of surgical pathology at the Cleveland Clinic stated, “When we’re talking about tumors, we’re talking about what information can we gain about that tumor to guide and direct therapy, prognosis, diagnostics. We believe this technology to be a game changer. It will take personalized medicine to an entirely new level. This is not a step, but a leap. Being able to analyze multiple markers in a single cell to understand the behavior of actual signaling pathways will significantly aid in disease diagnosis and therapy development.” Dr. Hunt went on to add, “I expect that this technology will be rapidly adopted across the field of pathology.”

The list of devices and technologies was selected by a panel of physicians and scientists affiliated with the Cleveland Clinic, and was unveiled during the annual Medical Innovation Summit this week.

“We are honored and grateful that this technology was recognized by the Clinic,” says George Abe, CEO of CRi. “We are dedicated to developing comprehensive solutions that will help produce breakthroughs in biomedical research and medical care.”

As biological imaging becomes more about studying complex systems rather than single events, CRi’s NuanceTM system allows users to monitor more than one event or target at a time. The system produces clear and accurate unmixed images from a multi-label tissue section, whether the tissue is labeled for cellular, nuclear, or membrane markers that overlap spatially or spectrally.

“Our Nuance technology is like enabling a colorblind person to see color for the first time,” adds Clifford Hoyt, Chief Technology Officer of CRi. “Among other things, it can be used by both pre-clinical and clinical research scientists to reveal new data to expedite targeted therapies, and by physicians for personalized treatment.”

Four major criteria served as the basis for qualifying and selecting Cleveland Clinic’s Top 10 Medical Innovations. To receive consideration, a nominated innovation was required to: have significant potential for short-term clinical impact, have a high probability of success, be on the market or close to being introduced, and have sufficient data available to support its nomination.

Cambridge Research & Instrumentation, Inc (CRi) is a Boston-based biomedical imaging company providing innovative optical imaging solutions for more than 20 years. CRi’s multidisciplinary team is dedicated to providing comprehensive solutions that enable customers to produce breakthroughs in research and medical care. CRi technology helps extract new disease-specific information from biological and clinical samples in the physiological, morphological, and biochemical context of intact tissues and organisms.

With over 80 patents pending and issued, CRi’s award-winning innovations are being utilized around the world in a wide range of settings, ranging from academic researcher to pharmaceutical drug development to clinical medicine. CRi is headquartered in Woburn, Massachusetts, and operates a state-of-the-art manufacturing facility and is able to rapidly design and manufacture system-level solutions for a variety of growing market applications.

Visit http://www.cri-inc.com/nuance to find out more about the Nuance system.

For more information visit our website at www.cri-inc.com or contact:

Ross Nakatsuji

CRi Marketing/Sales Group Leader

35-B Cabot Road, Woburn, MA 01801 USA

(P) 1-781-935-9099, extension 177, (C) 1-781-405-4000, (E) rnakatsuji@cri-inc.com

Cleveland Clinic Recognizes Multispectral Imaging as Top 10 Medical Innovation for 2009
Cambridge Research & Instrumentation, Inc. (CRi) announced today that the technology of multispectral imaging was ranked as a Top Ten Medical Innovation at Cleveland Clinic's 6th Annual Medical Innovations Summit. »

Latest News

Datawatch Self-Service Data Preparation Platform in High Demand in Healthcare Market

NWN Recognized in CRN Elite 150 For Managed IT Services and Placed on Managed Service Provider 500 List

Bigbelly Unveils Top 2016 Successes for Optimized Collections & Recycling Diversion

Southern California Edison Awards Cadmus MSA to Support Zero Net Energy Schools

» More News


Latest Newsletters

April 2017 – MCRC Announces a New Investment in Baynes Electric Supply

March 2017 – Mass Capital Announces a New Investment in Tri-Wire Engineering Solutions, Inc.

July 2016 – Mass Capital Announces a New Investment in The Cadmus Group, Inc.

» More Newsletters


Archives!